会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • METHOD OF DELIPIDATION AND/OR TERMINAL STERILIZATION FOR BONE MATERIAL
    • 骨质疏松和/或终端消毒方法
    • US20150258245A1
    • 2015-09-17
    • US14209499
    • 2014-03-13
    • Warsaw Orthopedic. Inc.
    • Keyvan BehnamGuobao WeiNanette ForsythJames A. Beisser
    • A61L27/36A61L2/00
    • A61L27/3687A61L2/0082A61L27/3608A61L27/3691A61L2430/02
    • Methods for delipidation, viral inactivation and terminal sterilization are provided for bone grafting material. The methods include contacting bone material with an amount of supercritical fluid effective to remove at least lipids and at least contaminants from the bone material, thereby obtaining a terminally sterilized and delipidated bone material. In various embodiments, the substantially terminally sterilized and delipidated bone material is 99.0%, 99.5% or 99.9% free of lipids and contaminants. Contaminants that are removed from bone material by terminal sterilization with supercritical fluid include infectious organisms, such as bacteria, viruses, protozoa, parasites, fungi and mold. Bone material or bone compositions that can be treated with critical or supercritical fluids comprise mineralized or demineralized bone particles, mineralized or demineralized bone matrix, partially demineralized bone matrix or combinations thereof.
    • 为骨移植材料提供脱脂,病毒灭活和末端灭菌的方法。 所述方法包括使骨材料与一定量的超临界流体接触,该超临界流体有效地从骨材料中除去至少脂质和至少污染物,从而获得终末消毒和脱脂的骨材料。 在各种实施方案中,基本上终末灭菌和脱脂的骨材料为99.0%,99.5%或99.9%,不含脂质和污染物。 通过用超临界流体终端灭菌从骨材料中除去的污染物包括感染性生物,如细菌,病毒,原生动物,寄生虫,真菌和霉菌。 可以用临界或超临界流体处理的骨材料或骨组合物包括矿化或脱矿质骨颗粒,矿化或软化骨基质,部分软化骨基质或其组合。
    • 4. 发明授权
    • Bone matrix compositions and methods
    • 骨基质组成和方法
    • US08758792B2
    • 2014-06-24
    • US13746516
    • 2013-01-22
    • Warsaw Orthopedic, Inc.
    • Keyvan BehnamGuobao WeiNanette Forsyth
    • A61K35/00A61K35/32
    • A61K35/00A61F2/28A61F2002/30059A61F2310/00359A61K35/32A61L27/3604A61L27/3608A61L27/3683A61L27/3695A61L27/3834A61L27/54A61L2430/02A61L2430/40
    • Osteoinductive compositions and implants having increased biological activities, and methods for their production, are provided. The biological activities that may be increased include, but are not limited to, bone forming; bone healing; osteoinductive activity, osteogenic activity, chondrogenic activity, wound healing activity, neurogenic activity, contraction-inducing activity, mitosis-inducing activity, differentiation-inducing activity, chemotactic activity, angiogenic or vasculogenic activity, and exocytosis or endocytosis-inducing activity. In one embodiment, a method for producing an osteoinductive composition comprises providing partially demineralized bone, treating the partially demineralized bone to disrupt the collagen structure of the bone, and optionally providing a tissue-derived extract and adding the tissue-derived extract to the partially demineralized bone. In another embodiment, an implantable osteoinductive and osteoconductive composition comprises partially demineralized bone, wherein the collagen structure of the bone has been disrupted, and, optionally, a tissue-derived extract.
    • 提供具有增加的生物活性的骨诱导组合物和植入物及其生产方法。 可能增加的生物活性包括但不限于骨形成; 骨愈合; 骨诱导活性,成骨活性,软骨形成活性,伤口愈合活性,神经源性活性,收缩诱导活性,有丝分裂诱导活性,分化诱导活性,趋化活性,血管生成或血管发生活性,以及​​胞吐作用或内吞诱导活性。 在一个实施方案中,用于产生骨诱导性组合物的方法包括提供部分去矿物质的骨,处理所述部分去矿物质的骨以破坏所述骨的胶原结构,以及任选地提供组织衍生的提取物并将所述组织衍生的提取物加入到部分去矿物质 骨。 在另一个实施方案中,可植入的骨诱导和骨传导性组合物包含部分脱矿质骨,其中所述骨的胶原结构已被破坏,并且任选地包含组织衍生的提取物。
    • 7. 发明授权
    • Osteoinductive demineralized cancellous bone
    • 骨诱导软骨松质骨
    • US09415136B2
    • 2016-08-16
    • US14286640
    • 2014-05-23
    • WARSAW ORTHOPEDIC, INC.
    • Keyvan BehnamNanette ForsythJames RussellJohn WinterbottomTodd Boyce
    • A61L27/36A61F2/28A61L27/38A61K35/32A61F2/30
    • A61K35/32A61F2/28A61F2002/2817A61F2002/30059A61F2310/00359A61L27/3608A61L27/3641A61L27/3645A61L27/3683A61L27/3687A61L27/3691A61L27/3695A61L27/3878A61L2430/02
    • An osteoinductive demineralized bone matrix, corresponding osteoimplants, and methods for making the osteoinductive demineralized bone matrix are disclosed. The osteoinductive demineralized bone matrix may be prepared by providing demineralized bone and altering the collagenous structure of the bone. The osteoinductive demineralized bone matrix may also be prepared by providing demineralized bone and compacting the bone, for example via mechanical compaction, grinding into a particulate, or treatment with a chemical. Additives such as growth factors or bioactive agents may be added to the osteoinductive demineralized bone matrix. The osteoinductive demineralized bone matrix may form an osteogenic osteoimplant. The osteoimplant, when implanted in a mammalian body, may induce at the locus of the implant the full developmental cascade of endochondral bone formation including vascularization, mineralization, and bone marrow differentiation. The osteoinductive demineralized bone matrix may also be used as a delivery device to administer bioactive agents.
    • 公开了一种骨诱导的软骨骨架,相应的骨关节植入物以及用于制造骨诱导性软骨骨架的方法。 可以通过提供软化骨和改变骨的胶原结构来制备骨诱导的软骨骨架。 还可以通过提供脱矿质骨和压实骨,例如通过机械压实,研磨成颗粒或用化学品处理来制备骨诱导的软化骨基质。 添加剂如生长因子或生物活性剂可以加入到骨诱导的软化骨基质中。 骨诱导的骨质疏松骨质可形成成骨植骨。 当植入植入哺乳动物体内的植骨植入物可能在植入物的位置诱导软骨内骨形成的完全发育级联,包括血管化,矿化和骨髓分化。 骨诱导的软化骨基质也可以用作施用生物活性剂的递送装置。
    • 8. 发明申请
    • BONE MATRIX COMPOSITIONS AND METHODS
    • 骨基质组合物和方法
    • US20160144075A1
    • 2016-05-26
    • US14885649
    • 2015-10-16
    • Warsaw Orthopedic, Inc.
    • Keyvan BehnamGuobao WeiNanette Forsyth
    • A61L27/36A61L27/54
    • A61K35/00A61F2/28A61F2002/30059A61F2310/00359A61K35/32A61L27/3604A61L27/3608A61L27/3683A61L27/3695A61L27/3834A61L27/54A61L2430/02A61L2430/40
    • Osteoinductive compositions and implants having increased biological activities, and methods for their production, are provided. The biological activities that may be increased include, but are not limited to, bone forming; bone healing; osteoinductive activity, osteogenic activity, chondrogenic activity, wound healing activity, neurogenic activity, contraction-inducing activity, mitosis-inducing activity, differentiation-inducing activity, chemotactic activity, angiogenic or vasculogenic activity, and exocytosis or endocytosis-inducing activity. In one embodiment, a method for producing an osteoinductive composition comprises providing partially demineralized bone, treating the partially demineralized bone to disrupt the collagen structure of the bone. In another embodiment, an implantable osteoinductive and osteoconductive composition comprises partially demineralized bone, wherein the collagen structure of the bone has been disrupted, and, optionally, a tissue-derived extract.
    • 提供具有增加的生物活性的骨诱导组合物和植入物及其生产方法。 可能增加的生物活性包括但不限于骨形成; 骨愈合; 骨诱导活性,成骨活性,软骨形成活性,伤口愈合活性,神经源性活性,收缩诱导活性,有丝分裂诱导活性,分化诱导活性,趋化活性,血管生成或血管发生活性,以及​​胞吐作用或内吞诱导活性。 在一个实施方案中,用于生产骨诱导性组合物的方法包括提供部分去矿物质的骨,处理所述部分去矿物质的骨以破坏所述骨的胶原结构。 在另一个实施方案中,可植入的骨诱导和骨传导性组合物包含部分脱矿质骨,其中所述骨的胶原结构已被破坏,并且任选地包含组织衍生的提取物。